WEBVTT
Kind: captions
Language: en

00:00:00.770 --> 00:00:03.220 

appetite<00:00:01.949> or<00:00:02.010> the<00:00:02.340> desire<00:00:02.489> for<00:00:02.729> food

00:00:03.220 --> 00:00:03.230 
appetite or the desire for food

00:00:03.230 --> 00:00:05.600 
appetite or the desire for food
diminishes<00:00:04.230> once<00:00:04.470> food<00:00:04.740> intake<00:00:05.160> brings<00:00:05.460> about

00:00:05.600 --> 00:00:05.610 
diminishes once food intake brings about

00:00:05.610 --> 00:00:09.650 
diminishes once food intake brings about
a<00:00:05.790> feeling<00:00:06.240> of<00:00:06.330> satiety<00:00:08.150> let's<00:00:09.150> look<00:00:09.389> at<00:00:09.539> how

00:00:09.650 --> 00:00:09.660 
a feeling of satiety let's look at how

00:00:09.660 --> 00:00:13.129 
a feeling of satiety let's look at how
this<00:00:09.809> usually<00:00:10.349> takes<00:00:10.620> place<00:00:11.539> our<00:00:12.539> area<00:00:12.959> of

00:00:13.129 --> 00:00:13.139 
this usually takes place our area of

00:00:13.139 --> 00:00:18.250 
this usually takes place our area of
focus<00:00:13.349> lies<00:00:13.919> within<00:00:14.219> the<00:00:14.459> intestinal<00:00:14.999> villi

00:00:18.250 --> 00:00:18.260 

00:00:18.260 --> 00:00:21.050 

microsomal<00:00:19.260> triglyceride<00:00:20.100> transfer<00:00:20.550> protein

00:00:21.050 --> 00:00:21.060 
microsomal triglyceride transfer protein

00:00:21.060 --> 00:00:24.260 
microsomal triglyceride transfer protein
or<00:00:21.270> MTP<00:00:22.170> is<00:00:22.380> an<00:00:22.740> enzyme<00:00:23.220> that<00:00:23.250> facilitates<00:00:24.090> the

00:00:24.260 --> 00:00:24.270 
or MTP is an enzyme that facilitates the

00:00:24.270 --> 00:00:26.840 
or MTP is an enzyme that facilitates the
packaging<00:00:24.750> of<00:00:24.840> fats<00:00:25.080> into<00:00:25.460> chylomicrons<00:00:26.460> for

00:00:26.840 --> 00:00:26.850 
packaging of fats into chylomicrons for

00:00:26.850 --> 00:00:29.720 
packaging of fats into chylomicrons for
absorption<00:00:27.180> into<00:00:27.570> the<00:00:27.750> body<00:00:27.930> as<00:00:28.490> part<00:00:29.490> of<00:00:29.580> this

00:00:29.720 --> 00:00:29.730 
absorption into the body as part of this

00:00:29.730 --> 00:00:32.390 
absorption into the body as part of this
normal<00:00:30.150> digestive<00:00:30.660> process<00:00:31.170> that<00:00:31.800> enters<00:00:32.250> the

00:00:32.390 --> 00:00:32.400 
normal digestive process that enters the

00:00:32.400 --> 00:00:33.140 
normal digestive process that enters the
enterocyte

00:00:33.140 --> 00:00:33.150 
enterocyte

00:00:33.150 --> 00:00:35.750 
enterocyte
in<00:00:34.020> response<00:00:34.530> to<00:00:34.740> the<00:00:34.829> presence<00:00:35.160> of<00:00:35.340> fat<00:00:35.550> in

00:00:35.750 --> 00:00:35.760 
in response to the presence of fat in

00:00:35.760 --> 00:00:38.390 
in response to the presence of fat in
the<00:00:35.850> enterocyte<00:00:36.500> hormones<00:00:37.500> such<00:00:37.740> as<00:00:37.770> peptide

00:00:38.390 --> 00:00:38.400 
the enterocyte hormones such as peptide

00:00:38.400 --> 00:00:41.510 
the enterocyte hormones such as peptide
YY<00:00:38.930> pyy<00:00:39.930> are<00:00:40.500> released<00:00:40.890> into<00:00:41.130> the<00:00:41.280> bloodstream

00:00:41.510 --> 00:00:41.520 
YY pyy are released into the bloodstream

00:00:41.520 --> 00:00:45.130 
YY pyy are released into the bloodstream
by<00:00:42.000> endocrine<00:00:42.480> cells<00:00:42.780> in<00:00:42.930> the<00:00:43.020> intestine

00:00:45.130 --> 00:00:45.140 

00:00:45.140 --> 00:00:48.200 

circulating<00:00:46.140> pyy<00:00:46.739> reaches<00:00:47.340> the<00:00:47.460> hypothalamus

00:00:48.200 --> 00:00:48.210 
circulating pyy reaches the hypothalamus

00:00:48.210 --> 00:00:51.170 
circulating pyy reaches the hypothalamus
in<00:00:48.390> the<00:00:48.450> brain<00:00:48.680> when<00:00:49.680> concentrations<00:00:50.460> of<00:00:50.640> pyy

00:00:51.170 --> 00:00:51.180 
in the brain when concentrations of pyy

00:00:51.180 --> 00:00:53.660 
in the brain when concentrations of pyy
are<00:00:51.420> high<00:00:51.630> enough<00:00:51.930> the<00:00:52.470> satiety<00:00:52.890> center<00:00:53.460> in

00:00:53.660 --> 00:00:53.670 
are high enough the satiety center in

00:00:53.670 --> 00:00:55.850 
are high enough the satiety center in
the<00:00:53.820> brain<00:00:54.059> signals<00:00:54.630> the<00:00:54.989> animal<00:00:55.410> to<00:00:55.590> stop

00:00:55.850 --> 00:00:55.860 
the brain signals the animal to stop

00:00:55.860 --> 00:01:00.530 
the brain signals the animal to stop
eating<00:00:57.770> by<00:00:58.770> targeting<00:00:59.280> the<00:00:59.460> MTP<00:00:59.850> enzyme

00:01:00.530 --> 00:01:00.540 
eating by targeting the MTP enzyme

00:01:00.540 --> 00:01:03.139 
eating by targeting the MTP enzyme
Pfizer<00:01:01.320> animal<00:01:01.890> health<00:01:02.160> has<00:01:02.579> developed<00:01:03.090> a

00:01:03.139 --> 00:01:03.149 
Pfizer animal health has developed a

00:01:03.149 --> 00:01:05.119 
Pfizer animal health has developed a
unique<00:01:03.180> treatment<00:01:04.019> option<00:01:04.320> for<00:01:04.739> weight<00:01:04.890> loss

00:01:05.119 --> 00:01:05.129 
unique treatment option for weight loss

00:01:05.129 --> 00:01:06.310 
unique treatment option for weight loss
in<00:01:05.370> dogs

00:01:06.310 --> 00:01:06.320 
in dogs

00:01:06.320 --> 00:01:08.890 
in dogs
slender<00:01:07.320> all<00:01:07.409> is<00:01:07.680> the<00:01:08.100> first<00:01:08.430> fda-approved

00:01:08.890 --> 00:01:08.900 
slender all is the first fda-approved

00:01:08.900 --> 00:01:11.510 
slender all is the first fda-approved
weight-loss<00:01:09.900> medication<00:01:10.620> for<00:01:10.920> use<00:01:11.070> in<00:01:11.280> dogs

00:01:11.510 --> 00:01:11.520 
weight-loss medication for use in dogs

00:01:11.520 --> 00:01:14.360 
weight-loss medication for use in dogs
the<00:01:12.150> primary<00:01:12.659> action<00:01:13.140> of<00:01:13.260> cilantro<00:01:13.710> is<00:01:13.950> to

00:01:14.360 --> 00:01:14.370 
the primary action of cilantro is to

00:01:14.370 --> 00:01:16.370 
the primary action of cilantro is to
reduce<00:01:14.670> food<00:01:14.940> intake<00:01:15.420> by<00:01:15.900> decreasing

00:01:16.370 --> 00:01:16.380 
reduce food intake by decreasing

00:01:16.380 --> 00:01:18.590 
reduce food intake by decreasing
appetite<00:01:17.390> cilantro

00:01:18.590 --> 00:01:18.600 
appetite cilantro

00:01:18.600 --> 00:01:20.890 
appetite cilantro
also<00:01:18.900> reduces<00:01:19.409> the<00:01:19.440> absorption<00:01:19.710> of<00:01:20.190> fat

00:01:20.890 --> 00:01:20.900 
also reduces the absorption of fat

00:01:20.900 --> 00:01:24.170 
also reduces the absorption of fat
however<00:01:21.900> it<00:01:22.830> is<00:01:23.040> important<00:01:23.549> to<00:01:23.610> note<00:01:23.940> that

00:01:24.170 --> 00:01:24.180 
however it is important to note that

00:01:24.180 --> 00:01:27.880 
however it is important to note that
cilantro<00:01:25.140> does<00:01:25.650> not<00:01:25.890> affect<00:01:26.250> its<00:01:26.430> digestion

00:01:27.880 --> 00:01:27.890 
cilantro does not affect its digestion

00:01:27.890 --> 00:01:29.920 
cilantro does not affect its digestion
here's<00:01:28.890> how<00:01:29.159> it<00:01:29.310> works

00:01:29.920 --> 00:01:29.930 
here's how it works

00:01:29.930 --> 00:01:33.770 
here's how it works
sled<00:01:30.930> Trull<00:01:31.200> is<00:01:31.470> an<00:01:32.100> orally<00:01:32.520> administered<00:01:32.780> MTP

00:01:33.770 --> 00:01:33.780 
sled Trull is an orally administered MTP

00:01:33.780 --> 00:01:36.620 
sled Trull is an orally administered MTP
inhibitor<00:01:34.290> that<00:01:34.520> is<00:01:35.520> highly<00:01:35.909> selective<00:01:36.450> for

00:01:36.620 --> 00:01:36.630 
inhibitor that is highly selective for

00:01:36.630 --> 00:01:38.390 
inhibitor that is highly selective for
the<00:01:36.720> cells<00:01:36.990> that<00:01:37.170> line<00:01:37.229> the<00:01:37.439> small<00:01:37.830> intestine

00:01:38.390 --> 00:01:38.400 
the cells that line the small intestine

00:01:38.400 --> 00:01:42.469 
the cells that line the small intestine
you<00:01:38.720> will<00:01:39.720> recall<00:01:40.110> that<00:01:40.640> MTP<00:01:41.640> is<00:01:41.820> an<00:01:42.060> enzyme

00:01:42.469 --> 00:01:42.479 
you will recall that MTP is an enzyme

00:01:42.479 --> 00:01:44.899 
you will recall that MTP is an enzyme
that<00:01:42.890> facilitates<00:01:43.890> the<00:01:44.040> absorption<00:01:44.460> of<00:01:44.670> fat

00:01:44.899 --> 00:01:44.909 
that facilitates the absorption of fat

00:01:44.909 --> 00:01:49.190 
that facilitates the absorption of fat
into<00:01:45.689> the<00:01:45.810> body<00:01:47.150> by<00:01:48.150> partially<00:01:48.630> inhibiting

00:01:49.190 --> 00:01:49.200 
into the body by partially inhibiting

00:01:49.200 --> 00:01:52.940 
into the body by partially inhibiting
MTP<00:01:49.939> sled<00:01:50.939> trawl<00:01:51.210> allows<00:01:52.080> a<00:01:52.110> higher<00:01:52.439> amount<00:01:52.650> of

00:01:52.940 --> 00:01:52.950 
MTP sled trawl allows a higher amount of

00:01:52.950 --> 00:01:55.010 
MTP sled trawl allows a higher amount of
fat<00:01:53.189> to<00:01:53.549> remain<00:01:53.850> within<00:01:54.180> the<00:01:54.270> enter<00:01:54.659> o<00:01:54.689> site

00:01:55.010 --> 00:01:55.020 
fat to remain within the enter o site

00:01:55.020 --> 00:01:57.710 
fat to remain within the enter o site
instead<00:01:55.530> of<00:01:55.590> passing<00:01:56.100> into<00:01:56.340> the<00:01:56.369> body<00:01:56.720> this

00:01:57.710 --> 00:01:57.720 
instead of passing into the body this

00:01:57.720 --> 00:02:00.319 
instead of passing into the body this
additional<00:01:58.350> fat<00:01:58.619> trapped<00:01:59.220> in<00:01:59.400> the<00:01:59.520> enterocyte

00:02:00.319 --> 00:02:00.329 
additional fat trapped in the enterocyte

00:02:00.329 --> 00:02:02.899 
additional fat trapped in the enterocyte
stimulates<00:02:01.320> the<00:02:01.500> release<00:02:01.619> of<00:02:02.009> consistently

00:02:02.899 --> 00:02:02.909 
stimulates the release of consistently

00:02:02.909 --> 00:02:05.510 
stimulates the release of consistently
higher<00:02:03.150> levels<00:02:03.600> of<00:02:03.689> pyy<00:02:04.320> and<00:02:04.619> other<00:02:05.250> got

00:02:05.510 --> 00:02:05.520 
higher levels of pyy and other got

00:02:05.520 --> 00:02:08.149 
higher levels of pyy and other got
hormones<00:02:05.850> into<00:02:06.450> the<00:02:06.479> bloodstream<00:02:06.720> as<00:02:07.290> the

00:02:08.149 --> 00:02:08.159 
hormones into the bloodstream as the

00:02:08.159 --> 00:02:10.729 
hormones into the bloodstream as the
amount<00:02:08.489> of<00:02:08.610> pyy<00:02:09.179> increases<00:02:09.840> so<00:02:10.440> does<00:02:10.500> the

00:02:10.729 --> 00:02:10.739 
amount of pyy increases so does the

00:02:10.739 --> 00:02:12.250 
amount of pyy increases so does the
sensation<00:02:11.280> of<00:02:11.370> satiety

00:02:12.250 --> 00:02:12.260 
sensation of satiety

00:02:12.260 --> 00:02:14.320 
sensation of satiety
leading<00:02:12.739> to<00:02:13.040> a<00:02:13.069> decrease<00:02:13.459> in<00:02:13.580> appetite<00:02:13.849> and

00:02:14.320 --> 00:02:14.330 
leading to a decrease in appetite and

00:02:14.330 --> 00:02:17.800 
leading to a decrease in appetite and
food<00:02:14.750> intake<00:02:15.250> dogs<00:02:16.250> lose<00:02:16.579> weight<00:02:16.879> as<00:02:17.329> a<00:02:17.360> result

00:02:17.800 --> 00:02:17.810 
food intake dogs lose weight as a result

00:02:17.810 --> 00:02:19.750 
food intake dogs lose weight as a result
of<00:02:18.019> the<00:02:18.140> dual<00:02:18.319> mode<00:02:18.590> of<00:02:18.769> action<00:02:19.099> of<00:02:19.220> Slynt<00:02:19.519> role

00:02:19.750 --> 00:02:19.760 
of the dual mode of action of Slynt role

00:02:19.760 --> 00:02:22.600 
of the dual mode of action of Slynt role
the<00:02:20.659> suppression<00:02:21.049> of<00:02:21.260> appetite<00:02:21.829> is<00:02:22.010> believed

00:02:22.600 --> 00:02:22.610 
the suppression of appetite is believed

00:02:22.610 --> 00:02:25.089 
the suppression of appetite is believed
to<00:02:22.760> account<00:02:23.150> for<00:02:23.239> approximately<00:02:23.470> 90%<00:02:24.470> of<00:02:24.950> the

00:02:25.089 --> 00:02:25.099 
to account for approximately 90% of the

00:02:25.099 --> 00:02:27.670 
to account for approximately 90% of the
clinical<00:02:25.489> efficacy<00:02:25.790> of<00:02:26.180> central<00:02:26.720> and<00:02:26.959> the

00:02:27.670 --> 00:02:27.680 
clinical efficacy of central and the

00:02:27.680 --> 00:02:29.770 
clinical efficacy of central and the
decrease<00:02:28.129> in<00:02:28.310> fat<00:02:28.519> absorption<00:02:28.730> is<00:02:29.239> believed

00:02:29.770 --> 00:02:29.780 
decrease in fat absorption is believed

00:02:29.780 --> 00:02:31.390 
decrease in fat absorption is believed
to<00:02:29.930> account<00:02:30.260> for<00:02:30.440> about<00:02:30.500> 10<00:02:30.920> percent<00:02:31.280> of<00:02:31.340> the

00:02:31.390 --> 00:02:31.400 
to account for about 10 percent of the

00:02:31.400 --> 00:02:35.020 
to account for about 10 percent of the
medications<00:02:32.030> activity<00:02:32.650> in<00:02:33.650> short<00:02:34.220> the<00:02:34.819> dog

00:02:35.020 --> 00:02:35.030 
medications activity in short the dog

00:02:35.030 --> 00:02:38.710 
medications activity in short the dog
eats<00:02:35.269> less<00:02:36.040> over<00:02:37.040> time<00:02:37.069> the<00:02:37.940> clinical<00:02:38.359> effect

00:02:38.710 --> 00:02:38.720 
eats less over time the clinical effect

00:02:38.720 --> 00:02:40.630 
eats less over time the clinical effect
of<00:02:38.900> these<00:02:39.170> combined<00:02:39.650> mechanisms<00:02:40.310> is

00:02:40.630 --> 00:02:40.640 
of these combined mechanisms is

00:02:40.640 --> 00:02:43.360 
of these combined mechanisms is
dependable<00:02:41.329> weight<00:02:41.599> loss<00:02:42.010> through<00:02:43.010> highly

00:02:43.360 --> 00:02:43.370 
dependable weight loss through highly

00:02:43.370 --> 00:02:46.479 
dependable weight loss through highly
selective<00:02:43.879> MTP<00:02:44.510> inhibition<00:02:45.319> cilantro<00:02:46.040> offers

00:02:46.479 --> 00:02:46.489 
selective MTP inhibition cilantro offers

00:02:46.489 --> 00:02:48.099 
selective MTP inhibition cilantro offers
the<00:02:46.640> promise<00:02:46.849> of<00:02:47.120> effective<00:02:47.629> and<00:02:47.840> reliable

00:02:48.099 --> 00:02:48.109 
the promise of effective and reliable

00:02:48.109 --> 00:02:52.300 
the promise of effective and reliable
management<00:02:48.980> of<00:02:49.069> canine<00:02:49.640> obesity<00:02:51.099> Slynt<00:02:52.099> role

00:02:52.300 --> 00:02:52.310 
management of canine obesity Slynt role

00:02:52.310 --> 00:02:53.949 
management of canine obesity Slynt role
should<00:02:52.549> not<00:02:52.700> be<00:02:52.849> used<00:02:53.060> in<00:02:53.269> cats<00:02:53.480> dogs

00:02:53.949 --> 00:02:53.959 
should not be used in cats dogs

00:02:53.959 --> 00:02:55.839 
should not be used in cats dogs
receiving<00:02:54.470> long-term<00:02:54.849> corticosteroid

00:02:55.839 --> 00:02:55.849 
receiving long-term corticosteroid

00:02:55.849 --> 00:02:57.580 
receiving long-term corticosteroid
therapy<00:02:55.879> or<00:02:56.599> in<00:02:56.810> dogs<00:02:57.019> with<00:02:57.260> liver<00:02:57.500> disease

00:02:57.580 --> 00:02:57.590 
therapy or in dogs with liver disease

00:02:57.590 --> 00:03:00.399 
therapy or in dogs with liver disease
the<00:02:58.489> most<00:02:58.639> common<00:02:59.060> side<00:02:59.239> effect<00:02:59.569> is<00:02:59.780> vomiting

00:03:00.399 --> 00:03:00.409 
the most common side effect is vomiting

00:03:00.409 --> 00:03:02.920 
the most common side effect is vomiting
in<00:03:00.590> addition<00:03:01.400> dogs<00:03:01.760> may<00:03:02.030> experience<00:03:02.510> diarrhea

00:03:02.920 --> 00:03:02.930 
in addition dogs may experience diarrhea

00:03:02.930 --> 00:03:05.949 
in addition dogs may experience diarrhea
lethargy<00:03:03.799> or<00:03:04.099> anorexia<00:03:04.849> the<00:03:05.420> client<00:03:05.780> should

00:03:05.949 --> 00:03:05.959 
lethargy or anorexia the client should

00:03:05.959 --> 00:03:07.809 
lethargy or anorexia the client should
be<00:03:06.109> made<00:03:06.290> aware<00:03:06.560> that<00:03:06.769> if<00:03:07.040> any<00:03:07.250> of<00:03:07.400> these<00:03:07.549> signs

00:03:07.809 --> 00:03:07.819 
be made aware that if any of these signs

00:03:07.819 --> 00:03:09.940 
be made aware that if any of these signs
persist<00:03:08.359> for<00:03:08.599> more<00:03:08.750> than<00:03:08.900> two<00:03:09.139> days<00:03:09.349> the<00:03:09.769> dog

00:03:09.940 --> 00:03:09.950 
persist for more than two days the dog

00:03:09.950 --> 00:03:12.729 
persist for more than two days the dog
should<00:03:10.220> be<00:03:10.280> reevaluated<00:03:11.109> cilantro<00:03:12.109> is<00:03:12.500> not

00:03:12.729 --> 00:03:12.739 
should be reevaluated cilantro is not

00:03:12.739 --> 00:03:14.319 
should be reevaluated cilantro is not
for<00:03:12.980> use<00:03:13.129> in<00:03:13.310> humans<00:03:13.489> under<00:03:14.120> any

00:03:14.319 --> 00:03:14.329 
for use in humans under any

00:03:14.329 --> 00:03:17.230 
for use in humans under any
circumstances

